Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.
Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check53 days agoChange DetectedThe website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.SummaryDifference3%
- Check60 days agoChange DetectedSeveral key health-related resources, including MedlinePlus and NIH links, have been removed from the website.SummaryDifference0.3%
- Check68 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to mesothelioma and rare diseases, while the previous version 2.12.1 has been removed.SummaryDifference4%
Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.